CD8A and neoplasm: In other solid cancers, immunotherapy response has been associated with immunological factors such as the presence of cytotoxic CD8+ T cell populations and expression of checkpoint ligands (i.e., programmed death-ligand 1, PD-L1) as well as tumor intrinsic factors such as TMB; however, this has not been established in CSCC cohorts.